Lipid lowering nutraceuticals in clinical practice: Position paper from an International Lipid Expert Panel

Cicero, A. F. G. and Colletti, A. and Bajraktari, G. and Descamps, O. and Djuric, D. M. and Ezhov, M. and Fras, Z. and Katsiki, N. and Langlois, M. and Latkovskis, G. and Panagiotakos, D. B. and Paragh, G. and Mikhailidis, D. P. and Mitchenko, O. and Paulweber, B. and Pella, D. and Pitsavos, C. and Reiner, Ž and Ray, K. K. and Rizzo, M. and Sahebkar, A. and Serban, M. C. and Sperling, L. S. and Toth, P. P. and Vinereanu, D. and Vrablík, M. and Wong, N. D. and Banach, M. (2017) Lipid lowering nutraceuticals in clinical practice: Position paper from an International Lipid Expert Panel. Archives of Medical Science, 13 (5). pp. 965-1005.

[img] Text
Lipid lowering nutraceuticals in clinical practice Position paper from an International Lipid Expert Panel.pdf

Download (875kB)
Item Type: Article
Additional Information: Cited By :106 Export Date: 16 February 2020 Correspondence Address: Cicero, A.F.G.; Atherosclerosis Research Center, Via Albertoni 15, Italy; email:
Uncontrolled Keywords: alpha tocopherol anthocyanin antilipemic agent berberine beta glucan carnitine chitosan curcumin Cynara scolymus extract epigallocatechin gallate ezetimibe gamma oryzanol garlic extract hydroxymethylglutaryl coenzyme A reductase inhibitor ispagula linolenic acid low density lipoprotein cholesterol mannan nutraceutical omega 3 fatty acid pantethine placebo policosanol probiotic agent rosuvastatin silymarin sinecatechins triacylglycerol unindexed drug xuezhikang abdominal discomfort abdominal distension abdominal pain artichoke Bifidobacterium animalis cardiovascular disease Citrus Citrus bergamia constipation diabetes mellitus diarrhea diet supplementation dietary fiber drug dose comparison drug dose titration drug efficacy drug safety drug withdrawal dyslipidemia elevated blood pressure familial hypercholesterolemia familial hyperlipemia fatigue flatulence folic acid deficiency gastrointestinal disease gastrointestinal symptom human hypercholesterolemia hyperlipidemia hypertriglyceridemia iron deficiency kidney injury Lactobacillus acidophilus Lactobacillus plantarum lifestyle modification liver disease metabolic syndrome X musculoskeletal disease myopathy nonalcoholic fatty liver nonhuman patient compliance prevalence rash Review rhabdomyolysis risk reduction Spirulina vomiting weight reduction
Subjects: WD Nutrition Disease and metabolic diseases
QU Biochemistry
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib3 lib3
Date Deposited: 18 May 2020 09:00
Last Modified: 18 May 2020 09:00

Actions (login required)

View Item View Item